Biotechnology: Biological Products (No Diagnostic Substances). Health Care. Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio ...
News
- Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors - Quantisnow
- Angle PLC Announces HER2 Presentation at SABCS - BioSpace
WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUM. Independent findings support ANGLE's HER2 assay ...
- Agendia To Unveil Enhanced Breast Cancer Therapy at San Antonio - Yahoo
By Karen Roman Agendia, Inc. said it will present data to assess treatment decisions on patients with early-stage breast cancer at the San Antonio ...
- Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK ... - ABC4 Utah
("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology ... San Antonio Breast Cancer Symposium being held December 10-13, at ...
- Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before ...
Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before Surgery and Prevent Metastasis at the 2024 San Antonio Breast ...